When Antibiotics Fail: MIT Scientists Use AI To Target “Sleeper” Bacteria

  • 📰 SciTechDaily1
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 68%

United States Headlines News

United States Latest News,United States Headlines

Science, Space and Technology News 2024

AI-driven research is revolutionizing antibiotic discovery by identifying compounds like semapimod, which can combat dormant bacteria and breach the defenses of resistant Gram-negative bacteria. Credit: SciTechDaily.com

Still from a time-lapse microscopy video of E. coli cells treated with semapimod in the presence of SYTOX Blue. Credit: Image courtesy of the researchers“Resistance is happening more over time, and recurring infections are due to this dormancy,” says Jackie Valeri, a formerAbdul Latif Jameel Clinic for Machine Learning in Health) who recently earned her PhD in biological engineering from the Collins Lab.

Source: Tech Daily Report (techdailyreport.net)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 84. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

MIT’s AI Breakthrough: Pioneering New Antibiotics To Combat MRSAScience, Space and Technology News 2024
Source: SciTechDaily1 - 🏆 84. / 68 Read more »

Harvard and MIT fail ADL antisemitism testHarvard and MIT are two of 13 institutions of higher education that failed the Anti-Defamation League's antisemitism assessment.
Source: dcexaminer - 🏆 6. / 94 Read more »

Superbug Slayer: New Class of Antibiotics Proves Potent Against Multi-Drug Resistant BacteriaScience, Space and Technology News 2024
Source: SciTechDaily1 - 🏆 84. / 68 Read more »

Possible alternative to antibiotics produced by bacteriaMany bacteria produce substances to gain an advantage over competitors in their highly competitive natural environment. Researchers have discovered a new so-called lantibiotic, namely epilancin A37. It is produced by staphylococci that colonize the skin and acts specifically against their main competitors there, the corynebacteria.
Source: ScienceDaily - 🏆 452. / 53 Read more »

Rise seen in use of antibiotics for conditions they can't treat -- including COVID-19America is going the wrong way when it comes to prescribing antibiotics, with 1 in 4 prescriptions going to patients who have conditions that the drugs won t touch, a new study finds.
Source: ScienceDaily - 🏆 452. / 53 Read more »

Researchers uncover details of how bacteria build protective barriers, may inform new antibioticsYale researchers have uncovered new details on how bacteria like E. coli build their protective barriers, which will inform new antibiotic development.
Source: physorg_com - 🏆 388. / 55 Read more »